W Otter1, S Kleybrink, W Doering, E Standl, O Schnell. 1. Department of Cardiology, Schwabing City Hospital and Diabetes Research Institute, Munich, Germany. W.Otter@t-online.de
Abstract
AIMS: To assess hospital mortality and morbidity in diabetic and non-diabetic patients with acute myocardial infarction and to compare the results between the two groups. METHODS: All patients admitted in 1999 to the intensive care unit of the Schwabing City Hospital with diagnosis of acute myocardial infarction were assessed for hospital mortality and co-morbidity. RESULTS: Three hundred and thirty patients with acute myocardial infarction were admitted. Of those, 126 (38%) were diabetic and 204 (62%) were non-diabetic patients. Mortality within 24 h after admission was 13.5% in diabetic patients and 5.4% in non-diabetic patients (P<0.01). Mortality during entire hospitalization was higher in diabetic than in non-diabetic patients (29.4% vs. 16.2%; P=0.004). Diabetic patients were resuscitated more frequently than non-diabetic patients (24% vs. 11%, P<0.01). In diabetic patients, heart rate at admission was increased (91 +/- 27 vs. 82 +/- 23/min; P<0.01) and presence of angina pectoris was reported less frequently (59% (n=72) vs. 82% (n=167); P<0.001). Preceding myocardial infarction, microalbuminuria, peripheral artery disease and arterial hypertension were more frequent in diabetic than in non-diabetic patients. Diabetic patients demonstrated higher C-reactive protein (CRP) levels than non-diabetic patients (91.4 +/- 78.2 mg/l vs. 45.2 +/- 62.4 mg/l; P<0.001). CONCLUSIONS: In diabetic patients with acute myocardial infarction, early hospital mortality is increased and signs of cardiac autonomic dysfunction and microangiopathy are detected more frequently than in non-diabetic patients. The need for advanced treatment strategies early in the course of diabetic patients with myocardial infarction is emphasized.
AIMS: To assess hospital mortality and morbidity in diabetic and non-diabeticpatients with acute myocardial infarction and to compare the results between the two groups. METHODS: All patients admitted in 1999 to the intensive care unit of the Schwabing City Hospital with diagnosis of acute myocardial infarction were assessed for hospital mortality and co-morbidity. RESULTS: Three hundred and thirty patients with acute myocardial infarction were admitted. Of those, 126 (38%) were diabetic and 204 (62%) were non-diabeticpatients. Mortality within 24 h after admission was 13.5% in diabeticpatients and 5.4% in non-diabeticpatients (P<0.01). Mortality during entire hospitalization was higher in diabetic than in non-diabeticpatients (29.4% vs. 16.2%; P=0.004). Diabeticpatients were resuscitated more frequently than non-diabeticpatients (24% vs. 11%, P<0.01). In diabeticpatients, heart rate at admission was increased (91 +/- 27 vs. 82 +/- 23/min; P<0.01) and presence of angina pectoris was reported less frequently (59% (n=72) vs. 82% (n=167); P<0.001). Preceding myocardial infarction, microalbuminuria, peripheral artery disease and arterial hypertension were more frequent in diabetic than in non-diabeticpatients. Diabeticpatients demonstrated higher C-reactive protein (CRP) levels than non-diabeticpatients (91.4 +/- 78.2 mg/l vs. 45.2 +/- 62.4 mg/l; P<0.001). CONCLUSIONS: In diabeticpatients with acute myocardial infarction, early hospital mortality is increased and signs of cardiac autonomic dysfunction and microangiopathy are detected more frequently than in non-diabeticpatients. The need for advanced treatment strategies early in the course of diabeticpatients with myocardial infarction is emphasized.
Authors: R Doerr; U Hoffmann; W Otter; L Heinemann; W Hunger-Battefeld; B Kulzer; A Klinge; V Lodwig; I Amann-Zalan; D Sturm; D Tschoepe; S G Spitzer; J Stumpf; T Lohmann; O Schnell Journal: Diabetologia Date: 2011-07-20 Impact factor: 10.122
Authors: Vasilios G Athyros; Thomas D Gossios; Konstantinos Tziomalos; Matilda Florentin; Asterios Karagiannis; Dimitri P Mikhailidis Journal: Arch Med Sci Date: 2011-12-30 Impact factor: 3.318
Authors: Daniel I Bromage; Tom R Godec; Mar Pujades-Rodriguez; Arturo Gonzalez-Izquierdo; S Denaxas; Harry Hemingway; Derek M Yellon Journal: Cardiovasc Diabetol Date: 2019-12-09 Impact factor: 8.949